2024. Examining the Therapeutic Potential of CRISPR-Cas9 Gene Editing in Spondyloarthritis: Efficacy of TNF Inhibitor Adalimumab: Research Article. International Journal of Research in Medical and Clinical Science. 2, 02 (Jul. 2024), 20–30. DOI:https://doi.org/10.70829/ijrmcs.v2.i2.0724002.